Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells

scientific article published on 16 March 2020

Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/CANCERS12030698
P932PMC publication ID7140041
P698PubMed publication ID32187978

P50authorAkihisa TakahashiQ60968115
Sei SaiQ90432658
P2093author name stringMi-Sook Kim
Akira Fujimori
Tatsuya Ohno
Eun Ho Kim
Masao Suzuki
Akiko Uzawa
Guillaume Vares
P2860cites workEffects of carbon ion beam alone or in combination with cisplatin on malignant mesothelioma cells in vitro.Q52723011
Radiotherapy for local control of osteosarcoma.Q53627639
miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.Q54194621
Carbon ion radiotherapy for inoperable pediatric osteosarcoma.Q55017855
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phasQ61684809
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathwaysQ64119988
Targeting PI3K in cancer: mechanisms and advances in clinical trialsQ64254413
Cervical spine osteosarcoma treated with carbon-ion radiotherapyQ79396557
Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunkQ83498129
Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma CellsQ91377125
Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical CancerQ91566302
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcomaQ91732236
Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysisQ92486119
Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB signalingQ93026233
Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the PelvisQ33276486
Osteosarcoma OverviewQ33725511
Osteosarcoma treatment - where do we stand? A state of the art review.Q34392457
Osteosarcoma: a review of diagnosis, management, and treatment strategies.Q34626942
Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1Q34760588
Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice.Q34829069
Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivoQ35742348
The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review.Q35998959
Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitroQ36027858
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancerQ36745379
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastasesQ37403207
Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcomaQ37688626
The role of radiotherapy in oseosarcomaQ37705045
microRNAs in cancer management.Q38015027
New targets and approaches in osteosarcoma.Q38043913
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experienceQ38339108
Update on Survival in OsteosarcomaQ38651549
Zoledronic Acid Inhibits the Motility of Cancer Stem-like Cells from the Human Breast Cancer Cell Line MDA-MB 231.Q38732878
Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutationsQ38775720
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.Q38791765
Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signalingQ39225762
Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cellsQ39270354
The mechanism involved in the loss of PTEN expression in NSCLC tumor cellsQ39404103
Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-raysQ39567497
High-Dose Hypofractionated Radiation Therapy for Noncompressive Vertebral Metastases in Combination With Zoledronate: A Phase 1 Study.Q40509415
Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid CarcinomaQ41241592
Zoledronic acid in the management of metastatic bone diseaseQ41687221
Zoledronic acid augments the radiosensitivity of cancer cells through perturbing S- and M-phase cyclins and p21CIP1 expressionQ41701781
Carbon ion radiotherapy for localized primary sarcoma of the extremities: results of a phase I/II trialQ44754958
Restoration of miR-29b exerts anti-cancer effects on glioblastoma.Q47095704
MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysisQ47160717
Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosisQ47233291
Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).Q47663622
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.Q48408434
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageJQ1659584
P433issue3
P921main subjectzoledronic acidQ218507
P577publication date2020-03-16
P1433published inCancersQ27722963
P1476titleCarbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells
P478volume12

Reverse relations

Q98290391Ubiquitin-like protein FAT10 promotes osteosarcoma glycolysis and growth by upregulating PFKFB3 via stabilization of EGFRcites workP2860

Search more.